Page 682 - Williams Hematology ( PDFDrive )
P. 682

657




                  CHAPTER 45                                            primary process of metastasis and occurs often as a result of loss of
                                                                        E-cadherin. E-cadherin is a calcium-dependent cell adhesion molecule
                  ANEMIA ASSOCIATED WITH                                that likely plays a role in intercellular adhesion and inhibition of inva-
                                                                        sion by neoplastic cells. The loss of E-cadherin can be caused by many
                                                                                                               3
                  MARROW INFILTRATION                                   mechanisms, including mutations and gene silencing.  Dysregulation of
                                                                        calcium influx pathways through stromal interaction molecule (STIM)
                                                                        and calcium-permeable transient receptor potential (TRP) also plays a
                                                                        role in tumor invasive and metastatic behavior.  Many members of the
                                                                                                          4
                  Vishnu VB Reddy and Josef  T.  Prchal                 family of matrix metalloproteinases can also participate in the process
                                                                        of tumor cell invasion. Stromal cells, such as tumor-associated macro-
                                                                        phages, and growth factors secreted by them, such as fibroblast growth
                                                                        factor, are also known to promote tumor spread. 5
                    SUMMARY                                                 Table 45–1 lists the most common causes of extensive cellu-
                                                                        lar infiltration of marrow. In myelofibrotic disorders of both primary
                    Myelophthisic anemia is caused by marrow infiltration, typically by metastatic   and secondary origin, the fibrosis/osteosclerosis-restricts the available
                    cancer, and by any nonhematopoietic conditions, for example, granulomatous   marrow space and disrupts marrow architecture (Chap. 86). The dis-
                    inflammation or fibrosis. It can present with an overt leukoerythroblastic   ruption may cause cytopenias with production of deformed red cells,
                    picture or with only a few teardrop-shaped red cells on a blood film. These   especially poikilocytes and teardrop-shaped cells, and premature
                    changes may represent an early spread of the tumor (or other nonhematopoi-  release of erythroblasts, myelocytes, and giant platelets. The leukocyte
                    etic tissue) to the marrow or may indicate massive replacement of the marrow   count also may be elevated. Similar abnormalities following marrow
                                                                                                                     6
                    space. The diagnosis can be made by standard marrow biopsy. Radioisotope   replacement by calcium oxalate crystals have been reported.  Anemia
                    scanning and magnetic resonance imaging, although not very sensitive, can   seen in metastatic cancer most frequently results from cytokine release
                                                                        leading to anemia of chronic inflammation (Chap. 37), iron deficiency
                    be helpful in locating the biopsy site and can also help in estimating the per-  as a result of gastrointestinal or uterine bleeding (Chap. 42), or other
                    centage of involvement of the marrow space.         nutritional deficiencies (Chaps. 41 and 44). However, marrow replace-
                                                                        ment causing a myelophthisic anemia as the sole cause of anemia also
                                                                        occurs. The marrow microenvironment is susceptible to implantation
                                                                        of bloodborne malignant cells. Almost all cancers can metastasize to
                     DEFINITION AND HISTORY                             the marrow, 7–11  but the most common are cancers of the lung, breast,
                                                                        and prostate. Metastatic foci in the marrow can be found in 20 to 30
                  Myelophthisic anemia is the term that has been used to describe diverse   percent of patients with small cell carcinoma of the lung at the time of
                  pathologic processes, including Fanconi anemia,  but currently refers   diagnosis, and in more than 50 percent of patients at autopsy. 12,13  Overt
                                                     1
                  to anemia resulting from the presence of spotty to massive marrow   leukoerythroblastic blood picture is less common, and its absence is not
                  infiltration with abnormal cells or tissue components. Strictly speak-  a reliable indicator that the marrow is not involved.
                  ing, the blasts of acute leukemia, plasma cells of myeloma, and cells of   The characteristic abnormalities observed in patients with myelo-
                  lymphoma, chronic leukemia, and myeloproliferative neoplasms fit this   phthisic anemia may result partly from an attempt for compensatory
                  definition. However, the term myelophthisic anemia  is best reserved for   extramedullary  blood  formation  that  generally  reflects  extramedul-
                                                       2
                  marrow replacement by nonhematologic tumors and nonhematopoietic   lary hematopoiesis predominantly from the spleen. A similar picture
                  tissue. Minimal to moderate involvement usually does not cause symp-  can be seen when the marrow is replaced by numerous granulomas, 14,15
                  toms or hematologic changes. Such infiltration is clinically significant,   for example, sarcoidosis, disseminated tuberculosis, fungal infections,
                  however, because in patients with an established diagnosis of cancer, it   or by macrophages containing indigestible lipids, as in Gaucher and
                  indicates metastatic dissemination of the tumor and usually an advanced   Niemann-Pick diseases (Chap. 72)  and in macrophage activation syn-
                                                                                                 16
                  stage. Although extensive infiltration may lead to anemia or even pan-  drome (MAS).
                  cytopenia, anemia can be frequently accompanied by an elevated leu-  Marrow necrosis  can be  an  underlying  cause  of myelophthisic
                  kocyte count, often with immature myeloid cells in the blood. Platelets   anemia. The morphologic picture, best observed in hematoxylin-and-
                  can be increased, decreased, or normal (megakaryocytic fragments   eosin–stained biopsy of marrow, consists of cell debris and occasional
                  are seen occasionally in the blood film). The findings accompanied by    necrotic  cells  in  an  eosinophilic  amorphus  background  (Fig.  45–1).
                                                                                                                          17
                  teardrop-shaped red cells (dacrocytes), prematurely released nucleated   Marrow necrosis is generally considered to be very uncommon,
                  red cells, and immature myeloid cells is referred to as leukoerythroblastic   accounting for less than 1 percent of marrow biopsies. Metastatic
                  reaction (Chaps. 2, 31, and 86), which generally reflects marrow replace-  tumors, acute lymphoblastic leukemia (children), and septicemia are
                  ment by tumor or extramedullary hematopoiesis.        generally the underlying cause, 17,18  but sickle cell disease 19–21  and arsenic
                                                                                                                    22
                                                                        therapy in acute promyelocytic leukemia are other causes.  Necrotic
                     ETIOLOGY AND PATHOGENESIS                          foci range from small to very extensive (<5 to 90 percent of the biopsy
                                                                        volume). Extensive necrosis often results in inability to perform flow
                  Tumor metastasis results from the complex interactions between the   cytometry/molecular analysis satisfactorily. A repeat biopsy at a differ-
                  tumor cells and the surrounding microenvironment. Invasion is the   ent site may be needed. 17,23,24
                                                                            Because myelophthisic anemia is so uncommon, only a few rig-
                                                                        orous studies of the pathogenesis of anemia in this entity have been
                                                           99m
                    Acronyms and Abbreviations: MRI, magnetic resonance imaging;  Tc, a radio-  conducted. In vitro study of hematopoietic progenitors reveals only a
                                                                                                                       25
                    isotope of technetium;  Tc sestamibi, a radioisotope of technetium attached to the   moderate decrease of their proportion and proliferative capacity.  Sim-
                                 99m
                    sestamibi molecule.                                 ilar reports of erythropoiesis quantitation by ferrokinetic studies reveal
                                                                        only a moderate defect (Chap. 32).  The following confounding factors
                                                                                                 26



          Kaushansky_chapter 45_p0657-0660.indd   657                                                                   9/17/15   6:40 PM
   677   678   679   680   681   682   683   684   685   686   687